WhitTier Trust Company’s Seres Therapeutics MCRB Stock Holding History

WhitTier Trust Company’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23	Closed	-$6K	–	968
2016 Q3	$6K	Hold	23	–	–	﹤0.01%	809
2016 Q2	$13K	Buy	+23	New	+$13.5K	﹤0.01%	740

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WhitTier Trust Company's MCRB Position: Q4 2016 in Review

WhitTier Trust Company sold out of Seres Therapeutics (MCRB) in Q4 2016, closing a stake of 23 shares — an estimated $6K sold.

WhitTier Trust Company first reported a position in MCRB in Q2 2016 and held it in 2 quarters. The position peaked at $13K in Q2 2016. 89 funds tracked by Wall St. Rank hold MCRB as of Q4 2016.

WhitTier Trust Company reported no remaining Seres Therapeutics position as of Q4 2016 after selling out during the quarter.
WhitTier Trust Company sold 23 Seres Therapeutics shares in Q4 2016, an estimated $6K.
WhitTier Trust Company first reported a position in Seres Therapeutics in Q2 2016 and held it in 2 quarters.
WhitTier Trust Company's Seres Therapeutics position peaked at $13K in Q2 2016.
89 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2016.

Based on WhitTier Trust Company's 13F filing for Q4 2016, filed 19 Jan 2017.